Hello treefeed,
Firstly, I appreciate your logic of the "zero sum game" with respect to the invoicing of spodumene from Mt Catlin
to Jiangsu and that "Mt Catlin's loss is Jiangsu's gain".
Our laws, however, prohibit transfer pricing, so inhouse
deals across borders by corporations have to reflect fair market value in invoicing unless a prior ruling is given.
Talison pricing next door provides that price yardstick.
I'm not saying that this is transfer pricing, but the inference from your post is that an 'zero sum game"
is fine, which it's not.
Secondly, If GXY's production costs are going to be $599/ton as per the Sept qtr and if Talisons export price
is $379.50/ton ($330 + the much publicised 15% price increase), then it would make better economic sense for GXY to buy its spodumene from Talison, at least until Mt Catlin reduces costs below $379.50/ton.
Keep in mind that Talisons quality is 6% li while GXY's is 5.5%.
Cheers & thank you for your post.
Moorookamick
- Forums
- ASX - By Stock
- GXY
- mt catlin viability
mt catlin viability, page-4
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)